A common habit shared by nearly 18 million Americans was found to increase the risk of oral cancer by more than three times, ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Align Technology. If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened ...

President Trump urges top pharmaceutical firms to lower U.S. drug prices under his most-favored-nation drug pricing policy ...

FDA recommends lifting the hold on Sarepta's gene therapy Elevidys for ambulatory patients after investigation; ...

Over the past decade, health insurance companies have increasingly embraced the use of artificial intelligence algorithms – ...

With a full year as jailer under her belt, Tracy Hopper updated the fiscal court about the progress being made at the ...

The gloomy, demon-invoking lead singer of the pioneering band Black Sabbath who became the throaty, growling voice of heavy ...

The deaths of Breonna Taylor and George Floyd became the focus of a wave of mass protests in the United States.

Discover CBL-514, a groundbreaking injection for targeted fat loss, offering a non-surgical alternative to liposuction with promising results.

VK2735 began phase 3 testing earlier this year, which is the final stage of trials necessary before the U.S. Food and Drug Administration (FDA) makes its ultimate approval decision.

Gov. Gavin Newsom announced July 18 that the High Speed Rail Authority is suing the Trump administration after the administration terminated over $4 billion in grants.

The U.S. Food & Drug Administration has granted orphan drug designation to Chicago-based Amphix Bio's treatment for acute spinal cord injury, or SCI. Its makers hope the drug could someday let ...